Axa Sa
AXA SA is a multinational insurance company that provides life and health insurance products, generating revenue through premium income and investment returns.
Business. AXA SA (AXAF.PA) is a life and health insurance company headquartered in France and primarily listed on the Euronext Paris. The firm operates within the Financials sector, generating revenue through a premium-income model typical of the insurance industry. Specific details regarding its operating segments and geographic mix are not provided in the available data.
Analyst recommendations
22 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
AXA SA (AXAF.PA) is a life and health insurance company headquartered in France and primarily listed on the Euronext Paris. The firm operates within the Financials sector, generating revenue through a premium-income model typical of the insurance industry. Specific details regarding its operating segments and geographic mix are not provided in the available data.
AXA SA's capital structure is characterized by a lack of dilution risk, as shares outstanding for both basic and diluted scenarios are identical at 2.06 billion shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's valuation snapshot is currently unavailable, but its price targets suggest a range of 40.00 EUR to 50.70 EUR, with a mean of 45.97 EUR and a median of 46.82 EUR.
Profitability and returns are not currently quantifiable due to the absence of valuation snapshot data. However, as a life and health insurer, AXA's performance is typically measured by metrics such as combined ratio, underwriting margin, and investment yield. These metrics are not provided in the current dataset, so a direct comparison to industry medians is not possible.
AXA's revenue is derived from its global operations, but the specific geographic and segment breakdown is not disclosed in the available data. The company operates in a highly regulated and competitive environment, and its exposure to regional markets is likely significant, though the exact concentration is not quantified in the input data.
Growth trajectory is not explicitly outlined in the input data, but analyst price targets suggest a relatively stable outlook. The mean recommendation of 1.91 indicates a slight bias toward positive sentiment, with 5 strong-buy and 14 buy ratings. No specific revenue history or growth rates are provided to support a more detailed growth narrative.
Risk factors include the inability to assess liquidity risk, which is a concern for any financial institution. The company is also exposed to regulatory and market risks inherent to the insurance industry, such as claims volatility and interest rate sensitivity. Dilution risk is currently low, as no dilution potential is reported in the data.
Recent events, such as filings or transcripts, are not included in the input data, so no specific recent developments can be cited. Analysts' price targets and recommendations are the most recent signals of market sentiment.
- AXA SA has no dilution risk as of the latest data, with basic and diluted shares outstanding being equal.
- Analysts have a generally positive outlook, with a mean recommendation of 1.91 and a median price target of 46.82 EUR.
- Liquidity risk could not be assessed due to missing balance-sheet inputs and no going-concern language in source documents.
- The company's profitability and returns are not currently quantifiable due to the absence of valuation snapshot data.
- AXA's geographic and segment revenue concentration is not disclosed in the available data.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Operating income −0,4% YoY; Net income +24,2% YoY.
- ▍Operating income −0,4% YoY
- ▍Net income +24,2% YoY
Operating income +18,4% YoY; Net income +9,7% YoY.
- ▍Operating income +18,4% YoY
- ▍Net income +9,7% YoY
Operating income +19,1% YoY; Net income +42,0% YoY.
- ▍Operating income +19,1% YoY
- ▍Net income +42,0% YoY
Operating income −10,7% YoY; Net income −30,6% YoY.
- ▍Operating income −10,7% YoY
- ▍Net income −30,6% YoY
Operating income €8.27B.
- ▍Operating income €8.27B
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 4,12 |
| Revenue | —no estimate | —no estimate | 94,5B EUR |
| Operating income | —no estimate | —no estimate | 10,4B EUR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- AXA SA Market data — financials · 2026-05-27
- AXA SA Market data — analyst estimates · 2026-05-27
Ownership & reference
Leadership
- Thomas BuberlChief Executive Officer, Executive Director